Mucopolysaccharidosis III (MPS III) (サンフィリッポ症候群)：グローバル臨床試験動向（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Shire Plc 27
Clinical Trial Overview of Shire Plc 27
UniQure NV 28
Clinical Trial Overview of UniQure NV 28
Lysogene 29
Clinical Trial Overview of Lysogene 29
Synageva BioPharma Corp. 30
Clinical Trial Overview of Synageva BioPharma Corp. 30
Cytomedix, Inc. 31
Clinical Trial Overview of Cytomedix, Inc. 31
BioMarin Pharmaceutical Inc. 32
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
Academic Medical Center 33
Clinical Trial Overview of Academic Medical Center 33
Masonic Cancer Center 34
Clinical Trial Overview of Masonic Cancer Center 34
The University of Manchester 35
Clinical Trial Overview of The University of Manchester 35
The University of Chicago 36
Clinical Trial Overview of The University of Chicago 36
Hospices Civils de Lyon 37
Clinical Trial Overview of Hospices Civils de Lyon 37
University of Louisville 38
Clinical Trial Overview of University of Louisville 38
University of Minnesota 39
Clinical Trial Overview of University of Minnesota 39
Five Key Clinical Profiles 40
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64